What does CUSIP 035255108 represent in this 13F holders report?

CUSIP 035255108 is the security identifier for ANIK - Anika Therapeutics Inc - Common Stock used to aggregate holder disclosures.

How many institutions held ANIK - Anika Therapeutics Inc - Common Stock in Q2 2017?

154 institutional investors reported ANIK - Anika Therapeutics Inc - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

Anika Therapeutics Inc - Common Stock (ANIK)

CUSIP: 035255108

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 13,404,566
Total 13F shares: 12,374,607
Share change: +522,975
Total reported value: $610,498,457
Put/Call ratio: 26%
Price per share: $49.34
Number of holders: 154
Value change: +$26,979,854
Number of buys: 75
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 035255108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	13%	1,787,525	$77,650,000	—	31 Mar 2017	13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	13F	Company	10%	1,335,175	$58,000,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	8.4%	1,126,330	$48,927,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	5.9%	791,242	$34,372,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	5.8%	771,699	$33,522,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	2.6%	349,292	$15,171,000	—	31 Mar 2017	13F
Boston Trust Walden Corp	13F	Company	2.5%	341,249	$14,824,000	—	31 Mar 2017	13F
THOMPSON SIEGEL & WALMSLEY LLC	13F	Company	2.1%	280,802	$12,198,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	2.1%	277,378	$12,049,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.9%	253,100	$10,995,000	—	31 Mar 2017	13F
AMI ASSET MANAGEMENT CORP	13F	Company	1.9%	251,262	$10,915,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	1.5%	195,071	$8,474,000	—	31 Mar 2017	13F
Atle Fund Management AB	13F	Company	1.4%	181,573	$7,888,000	—	31 Mar 2017	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.3%	170,229	$7,395,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	1.3%	169,077	$7,345,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.2%	166,674	$7,240,000	—	31 Mar 2017	13F
CAPITAL MANAGEMENT CORP /VA	13F	Company	1.1%	145,540	$6,322,000	—	31 Mar 2017	13F
STIFEL FINANCIAL CORP	13F	Company	1%	140,704	$6,119,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.88%	118,456	$5,146,000	—	31 Mar 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.88%	117,461	$5,103,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.87%	117,036	$5,084,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.67%	90,101	$3,914,000	—	31 Mar 2017	13F
NATIXIS ADVISORS, LLC	13F	Company	0.66%	87,998	$3,823,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.65%	86,892	$3,775,000	—	31 Mar 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.59%	78,629	$3,416,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.57%	76,435	$3,318,000	—	31 Mar 2017	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.57%	76,087	$3,305,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.54%	72,400	$3,145,000	—	31 Mar 2017	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.53%	71,519	$3,107,000	—	31 Mar 2017	13F
Fisher Asset Management, LLC	13F	Company	0.52%	70,153	$3,047,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	64,843	$2,817,000	—	31 Mar 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.47%	62,607	$2,720,000	—	31 Mar 2017	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.47%	62,340	$2,708,000	—	31 Mar 2017	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.45%	60,016	$2,607,000	—	31 Mar 2017	13F
NEW AMSTERDAM PARTNERS LLC/NY	13F	Company	0.41%	55,597	$2,415,000	—	31 Mar 2017	13F
South Dakota Investment Council	13F	Company	0.4%	53,031	$2,304,000	—	31 Mar 2017	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.39%	52,881	$2,297,000	—	31 Mar 2017	13F
HL FINANCIAL SERVICES LLC	13F	Company	0.39%	51,993	$2,259,000	—	31 Mar 2017	13F
Piermont Capital Management Inc.	13F	Company	0.37%	50,000	$2,172,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.35%	46,891	$2,037,000	—	31 Mar 2017	13F
Allianz Asset Management GmbH	13F	Company	0.34%	45,942	$1,996,000	—	31 Mar 2017	13F
Invesco Ltd.	13F	Company	0.34%	45,801	$1,990,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.3%	40,421	$1,757,000	—	31 Mar 2017	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.3%	40,229	$1,748,000	—	31 Mar 2017	13F
Freedom Investment Management, Inc.	13F	Company	0.27%	36,230	$1,574,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.27%	35,574	$1,545,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.27%	35,532	$1,544,000	—	31 Mar 2017	13F
Spark Investment Management LLC	13F	Company	0.26%	35,500	$1,542,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.26%	34,498	$1,499,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.24%	32,475	$1,411,000	—	31 Mar 2017	13F

Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q2 2017

As of 30 Jun 2017, Anika Therapeutics Inc - Common Stock (ANIK) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,374,607 shares. The largest 10 holders included BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, Bank of New York Mellon Corp, STATE STREET CORP, AMI ASSET MANAGEMENT CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, and BTIM Corp.. This page lists 154 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

152

Q2 2017 holders

154

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.